Does AMPHOTERICIN B Cause Cutaneous vasculitis? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Cutaneous vasculitis have been filed in association with AMPHOTERICIN B (Amphotericin B). This represents 0.2% of all adverse event reports for AMPHOTERICIN B.
20
Reports of Cutaneous vasculitis with AMPHOTERICIN B
0.2%
of all AMPHOTERICIN B reports
0
Deaths
18
Hospitalizations
How Dangerous Is Cutaneous vasculitis From AMPHOTERICIN B?
Of the 20 reports, 18 (90.0%) required hospitalization, and 18 (90.0%) were considered life-threatening.
Is Cutaneous vasculitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMPHOTERICIN B. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does AMPHOTERICIN B Cause?
Drug ineffective (4,151)
Off label use (1,529)
Condition aggravated (603)
Acute kidney injury (596)
Multiple organ dysfunction syndrome (465)
Pyrexia (388)
Death (379)
Hypokalaemia (353)
Renal impairment (328)
Septic shock (308)
What Other Drugs Cause Cutaneous vasculitis?
METHOTREXATE (207)
ADALIMUMAB (193)
TOCILIZUMAB (161)
ETANERCEPT (148)
APIXABAN (131)
HYDROXYCHLOROQUINE (125)
LEFLUNOMIDE (116)
ABATACEPT (112)
ANAKINRA (112)
INFLIXIMAB (108)
Which AMPHOTERICIN B Alternatives Have Lower Cutaneous vasculitis Risk?
AMPHOTERICIN B vs AMPHOTERICIN B\DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL-\DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL-
AMPHOTERICIN B vs AMPICILLIN
AMPHOTERICIN B vs AMPICILLIN\SULBACTAM
AMPHOTERICIN B vs AMPRENAVIR
AMPHOTERICIN B vs AMPYRA